Singapore markets closed
Straits Times Index
3,292.93 -3.96 (-0.12%) Nikkei
38,236.07 -37.98 (-0.10%) Hang Seng
18,475.92 +268.79 (+1.48%) FTSE 100
8,213.49 +41.34 (+0.51%) Bitcoin USD
61,623.95 +2,588.86 (+4.39%) CMC Crypto 200
1,335.93 +58.95 (+4.62%)
Kura Oncology, Inc. (KURA)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
As of 01:05PM EDT. Market open.
Currency in USD
Valuation measures4
| Market cap (intra-day) | 1.57B |
| Enterprise value | 1.16B |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | N/A |
| Price/book (mrq) | 3.95 |
| Enterprise value/revenue | N/A |
| Enterprise value/EBITDA | -7.73 |
Trading information
Stock price history
| Beta (5Y monthly) | N/A |
| 52-week change 3 | 80.77% |
| S&P500 52-week change 3 | 22.43% |
| 52-week high 3 | 24.17 |
| 52-week low 3 | 7.41 |
| 50-day moving average 3 | 20.62 |
| 200-day moving average 3 | 14.01 |
Share statistics
| Avg vol (3-month) 3 | 921.1k |
| Avg vol (10-day) 3 | 917.12k |
| Shares outstanding 5 | 76.18M |
| Implied shares outstanding 6 | 76.18M |
| Float 8 | 49.82M |
| % held by insiders 1 | 1.08% |
| % held by institutions 1 | 106.01% |
| Shares short (15 Apr 2024) 4 | 10.12M |
| Short ratio (15 Apr 2024) 4 | 11.66 |
| Short % of float (15 Apr 2024) 4 | 13.42% |
| Short % of shares outstanding (15 Apr 2024) 4 | 13.28% |
| Shares short (prior month 15 Mar 2024) 4 | 10.3M |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Mar 2024 |
Profitability
| Profit margin | 0.00% |
| Operating margin (ttm) | 0.00% |
Management effectiveness
| Return on assets (ttm) | N/A |
| Return on equity (ttm) | N/A |
Income statement
| Revenue (ttm) | N/A |
| Revenue per share (ttm) | N/A |
| Quarterly revenue growth (yoy) | N/A |
| Gross profit (ttm) | N/A |
| EBITDA | -182.83M |
| Net income avi to common (ttm) | -168.09M |
| Diluted EPS (ttm) | -2.08 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | N/A |
| Total cash per share (mrq) | N/A |
| Total debt (mrq) | N/A |
| Total debt/equity (mrq) | 4.33% |
| Current ratio (mrq) | N/A |
| Book value per share (mrq) | 5.34 |
Cash flow statement
| Operating cash flow (ttm) | N/A |
| Levered free cash flow (ttm) | N/A |
© 2024 Yahoo. All rights reserved.